Advanced search
Publication Cover
International Journal of Neuroscience Volume 120, 2010 - Issue 11
Submit an article Journal homepage
107
Views
13
CrossRef citations to date
0
Altmetric
Research Article

An Open-Label, Sequential Dose-Escalation, Safety, and Tolerability Study of Rimabotulinumtoxinb in Subjects With Cervical Dystonia

Robert ChinnapongseSolstice Neurosciences, LLC, Louisville, Kentucky, USACorrespondence[email protected]
,
Eric J. PappertSolstice Neurosciences, LLC, Louisville, Kentucky, USA
,
Marian EvattDepartment of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA
,
Alan FreemanDepartment of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA
&
William BirminghamSolstice Neurosciences, LLC, Louisville, Kentucky, USA
Pages 703-710 | Received 28 Jun 2010, Published online: 13 Oct 2010

REFERENCES

  • Brashear, A., Lew, M. F., Dykstra, D. D., Comella, C. L., Factor, S. A., Rodnitzky, R. L., (1999). Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology, 53(7), 1439–1446.
  • Brin, M. F., Lew, M. F., Adler, C. H., Comella, C. L., Factor, S. A., Jankovic, J., (1999). Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology, 53(7), 1431–1438.
  • Camfield, L., Ben-Shlomo, Y., & Warner, T. (2002). Epidemiological study of dystonia in Europe Collective Group. Movement Disorders, 17(4), 838–841.
  • Chan, J., Brin, M., & Fahn, S. (1991). Idiopathic cervical dystonia: Clinical characteristics. Movement Disorders, 6, 119–126.
  • Comella, C. L., Jankovic, J., Shannon, K. M., Tsui, J., Swenson, M., Leurgans, S., (2005). Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology, 65(1), 1423–1429.
  • Comella, C. L., Stebbins, G. T., Goetz, C. G., Chmura, T. A., Bressman, S. B., & Lang, A. E. (1997). Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Movement Disorders, 12(4), 570–575.
  • Comella, C. L., Tanner, C. M., DeFloor-Hill, L., & Smith, C. (1992). Dysphagia after botulinum toxin injections for spasmodic torticollis: Clinical and radiologic findings. Neurology, 42,1307–1310.
  • Consky, E. S., & Lang, A. E. (1994). Clinical assessments of patients with cervical dystonia. In J. Jankovic and M. Hallett (eds.), Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, Inc., 211–237.
  • Costa, J., Espírito-Santo, C., Borges, A., Ferreira, J. J., Coelho, M., Moore, P., (2004). BoNT-B for cervical dystonia. Cochrane Database of Systematic Reviews, Issue 4. Art. No. CD004315. DOI: 10.1002/14651858.CD004315.pub2.
  • Factor, S. A. (2002). Practical Considerations for the Clinical Use of Botulinum Toxin Type B: A Self-Study Continuing Medical Education Activity. New York, NY: WE MOVE.
  • Factor, S. A., Molho, E. S., Evans, S., & Feustel, P. J. (2005). Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia. Movement Disorders, 20(9), 1152–1160.
  • Jahanshahi, M., & Marsden, C. D. (1988). Depression in torticollis: A controlled study. Psychological Medicine, 18(4), 925–933.
  • Jahanshahi, M., & Marsden, C. D. (1990a). Body concept, disability, and depression in patients with spasmodic torticollis. Behavioural Neurology, 3, 117–131.
  • Jahanshahi, M., & Marsden, C. D. (1990b). A longitudinal follow-up study of depression, disability, and body concept in torticollis. Behavioural Neurology, 3, 233–246.
  • Jankovic, J., Leder, S., Warner, I., & Schwartz, K. (1991). Cervical dystonia: Clinical findings and associated movement disorders. Neurology, 41, 1088–1091.
  • Lew, M. F. (2002). Botulinum toxin type B: An effective treatment for alleviating pain associated with cervical dystonia. Journal of Back and Musculoskeletal Rehabilitation, 16, 3–9.
  • Lew, M. F., Adornato, B. T., Duane, D. D., Dykstra, D. D., Factor, S. A., Massey, J. M., (1997). Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology, 49(3), 701–707.
  • Lew, M. F., & Factor, S. A. (2006). A 4 year observational study of repeated dosing with botulinum toxin type B in patients with cervical dystonia [Abstract P05.127]. Neurology, 66(Suppl. 2), A290–A291.
  • Nutt, J. G., Muenter, M. D., Aronson, A., Kurland, L. T., & Melton, L. J., 3rd. (1988). Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Movement Disorders, 3(3), 188–194.
  • Pappert, E. J., & Germanson, T. (2008). Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, non-inferiority trial. Movement Disorders, 23(4), 510–517.
  • Van Zandijcke, M. (1995). Cervical dystonia (spasmodic torticollis). Some aspects of the natural history. Acta Neurologica Belgica, 95(4), 210–215.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.